Vertex to Announce First Quarter 2014 Financial Results on May 1

  Vertex to Announce First Quarter 2014 Financial Results on May 1

Business Wire

BOSTON -- April 10, 2014

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its first
quarter 2014 financial results on Thursday, May 1, 2014 after the financial
markets close. The company will host a conference call and webcast at 5:00
p.m. ET. To access the call, please dial (866) 501-1537 (U.S.) or +1 (720)
545-0001 (International).

The conference call will be webcast live and a link to the webcast may be
accessed through Vertex's website at www.vrtx.com in the "Investors" section
under "Events and Presentations.” To ensure a timely connection, it is
recommended that users register at least 15 minutes prior to the scheduled
webcast. An archived webcast will be available on the company's website until
June 30, 2014.

About Vertex

Vertex is a global biotechnology company that aims to discover, develop and
commercialize innovative medicines so people with serious diseases can lead
better lives. Vertex scientists and our collaborators are working on new
medicines to cure or significantly advance the treatment of cystic fibrosis,
hepatitis C, rheumatoid arthritis and other life-threatening diseases. In
addition to our clinical development programs, Vertex has more than a dozen
ongoing preclinical programs aimed at other serious and life-threatening
diseases.

Founded in 1989 in Cambridge, Mass., Vertex today has research and development
sites and commercial offices in the United States, Europe, Canada and
Australia. For four years in a row, Science magazine has named Vertex one of
its Top Employers in the life sciences. For additional information and the
latest updates from the company, please visit www.vrtx.com.

(VRTX-WEB)

Contact:

Vertex Pharmaceuticals Incorporated
Investors:
Michael Partridge, 617-341-6108
or
Kelly Lewis, 617-961-7530
 
Press spacebar to pause and continue. Press esc to stop.